Evidence map›Paper›PMID 30240051›Full record

ArticleClinical oral implants research2018

Injectable, compression-resistant polymer/ceramic composite bone grafts promote lateral ridge augmentation without protective mesh in a canine model.

Anne D Talley, Lauren A Boller, Kerem N Kalpakci, Daniel A Shimko, David L Cochran, Scott A Guelcher

Open access · greenAbstract read
In one paragraph

Article in Clinical oral implants research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Challenges of Engineering Biomimetic Dental and Paradental Tissues.Tissue engineering and regenerative medicine · 2020
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Anne D TalleyDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee.
Lauren A BollerDepartment of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee.
Kerem N KalpakciMedtronic Spinal & Biologics, Memphis, Tennessee.
Daniel A ShimkoMedtronic Spinal & Biologics, Memphis, Tennessee.
David L CochranDepartment of Periodontics, University of Texas Health Science Center at San Antonio, San Antonio, Texas.
Scott A GuelcherDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee.
Vanderbilt University · USMedtronic (United States) · USThe University of Texas Health Science Center at San Antonio · USUS Biologic (United States) · US

Funding

Integrated Training in Engineering and DiabetesT32DK101003 · NIDDK · VANDERBILT UNIVERSITY · PI Jamey D. Young · 2014 to 2026
$3.9M
Novel ultrahigh resolution microCT imaging systemS10RR027631 · NCRR · VANDERBILT UNIVERSITY · PI PERRIEN, DANIEL S · 2010 to 2010
$460k
Armed Forces Institute of Regenerative Medicine W81XWH-14-2-0004Department of EducationDivision of Materials Research 0847711Medical Research Acquisition ActivityNational Science FoundationNCRR NIH HHS S10 RR027631NIDDK NIH HHS T32 DK101003NIH HHS S10RR027631Office of Postsecondary Education P200A090323U.S. Army
6 · The paper itself

Abstract

objectiveThe objective of this study was to test the hypothesis that a compression-resistant bone graft augmented with recombinant human morphogenetic protein-2 (rhBMP-2) will promote lateral ridge augmentation without the use of protective mesh in a canine model. MATERIALS &

methodsCompression-resistant (CR) bone grafts were evaluated in a canine model of lateral ridge augmentation. Bilateral, right trapezoidal prism-shaped defects (13-14 mm long × 8-9 mm wide × 3-4 mm deep at the base) in 13 hounds (two defects per hound) were treated with one of four groups: (i) absorbable collagen sponge + 400 μg rhBMP-2/ml (ACS, clinical control) protected by titanium mesh, (ii) CR without rhBMP-2 (CR, negative control), (iii) CR + 200 μg rhBMP-2 (CR-L), or (iv) CR + 400 μg rhBMP-2 (CR-H). All animals were euthanized after 16 weeks. Ridge height and width and new bone formation were assessed by μCT, histology, and histomorphometry. The release kinetics of rhBMP-2 from CR bone grafts in vitro and in vivo in a femoral condyle defect model in rabbits was also evaluated.

resultsAll four bone grafts promoted new bone formation (11-31.6 volume%) in the lateral ridge defects. For CR grafts, ridge height and width increased in a dose-responsive manner with increasing rhBMP-2 concentration. Ridge height and width measured for CR-H without the use of protective mesh was comparable to that measured for ACS with a protective mesh.

conclusionsAt the same dose of rhBMP-2, an injectable, compression-resistant bone graft resulted in a comparable volume of new bone formation with the clinical control (ACS). These findings highlight the potential of compression-resistant bone grafts without the use of protective mesh for lateral ridge augmentation.

Indexed as

Alveolar ProcessAlveolar Ridge AugmentationAnimalsBone Morphogenetic Protein 2Bone TransplantationCeramicsDental MaterialsDogsMalePolymersRabbitsRecombinant ProteinsX-Ray MicrotomographyBMP2 protein, humanBone Morphogenetic Protein 2Dental MaterialsPolymersRecombinant Proteinsbone graftbone morphogenetic proteincanine modelcompression resistantlateral ridge augmentation

Identifiers

PMID30240051
PMCPMC6152823
OpenAlexW2803805716

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.